Therefore, agents able to prevent fibrosis by reducing TGF-β1 pathway, either directly or via modulation of upstream activating signals or epigenetic mechanisms, may be potentially beneficial to improving regeneration in DMD. Here, TGFB1 is linked to Duchenne muscular dystrophy.